Davis, David, Donners, Helen, WILLEMS, Betty, Lövgren-Bengtsson, Karin, Åkerblom, Lennart, Vanham, Guido, ...
Davis, David, Donners, Helen, WILLEMS, Betty, Lövgren-Bengtsson, Karin, Åkerblom, Lennart, Vanham, Guido, ...
Functional gross motor demands of the typical elementary classroom : an observational study / (1995)
Thesis (M.S. in O.T.)--Boston University, 1995.
A study of the Queensland native mounted police force in the 1870's [microform] / (1975)
Microform:[St. Lucia : University of Queensland, General Photographic Unit, 1980].
Heeney, Jonathan L., Teeuwsen, Vera J. P., Van Gils, Mariélle, Morghen, Carlo De Giuli, Radaelli, Antonia, ...
One of the obstacles to AIDS vaccine development is the variability of HIV-1 within individuals and within infected populations, enabling viral escape from highly specific vaccine induced immune...
VanCott, Thomas C., Mascola, John R., Loomis-Price, Lawrence D., Sinangil, Faruk, Zitomersky, Naamah, McNeil, John, ...
Global human immunodeficiency virus type 1 (HIV-1) diversity may require engineering vaccines to express antigens representing strains prevalent in the target population of vaccine testing. The...
O'Hagan, Derek, Singh, Manmohan, Ugozzoli, Mildred, Wild, Carl, Barnett, Susan, Chen, Minchao, ...
The effectiveness of cationic microparticles with adsorbed DNA at inducing immune responses was investigated in mice, guinea pigs, and rhesus macaques. Plasmid DNA vaccines encoding human...
Gupta, Soumi, Janani, Ramesh, Bin, Qian, Luciw, Paul, Greer, Catherine, Perri, Silvia, ...
A safe, replication-defective viral vector that can induce mucosal and systemic immune responses and confer protection against many infectious pathogens, such as human immunodeficiency virus type 1...
Otten, Gillis R., Schaefer, Mary, Doe, Barbara, Liu, Hong, Srivastava, Indresh, Zur Megede, Jan, ...
DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for...
Heeney, Jonathan L., Teeuwsen, Vera J. P., Van Gils, Mariélle, Morghen, Carlo De Giuli, Radaelli, Antonia, ...
One of the obstacles to AIDS vaccine development is the variability of HIV-1 within individuals and within infected populations, enabling viral escape from highly specific vaccine induced immune...
VanCott, Thomas C., Mascola, John R., Loomis-Price, Lawrence D., Sinangil, Faruk, Zitomersky, Naamah, McNeil, John, ...
Global human immunodeficiency virus type 1 (HIV-1) diversity may require engineering vaccines to express antigens representing strains prevalent in the target population of vaccine testing. The...
O'Hagan, Derek, Singh, Manmohan, Ugozzoli, Mildred, Wild, Carl, Barnett, Susan, Chen, Minchao, ...
The effectiveness of cationic microparticles with adsorbed DNA at inducing immune responses was investigated in mice, guinea pigs, and rhesus macaques. Plasmid DNA vaccines encoding human...
Gupta, Soumi, Janani, Ramesh, Bin, Qian, Luciw, Paul, Greer, Catherine, Perri, Silvia, ...
A safe, replication-defective viral vector that can induce mucosal and systemic immune responses and confer protection against many infectious pathogens, such as human immunodeficiency virus type 1...
Otten, Gillis R., Schaefer, Mary, Doe, Barbara, Liu, Hong, Srivastava, Indresh, Zur Megede, Jan, ...
DNA vaccines have been used widely in experimental primate models of human immunodeficiency virus (HIV), but their effectiveness has been limited. In this study, we evaluated three technologies for...